Latest News
Hims Expands Branded GLP-1 Access with Lilly's Zepbound and Foundayo
Hims & Hers Health now offers Eli Lilly's Zepbound and Foundayo via LillyDirect, broadening its branded GLP-1 lineup amid a competitive cash-pay market.
Texas Instruments Surges 16% After Strong Earnings and Outlook
Texas Instruments reported Q1 revenue of $4.83B, up 19%, and forecast Q2 above estimates, sending shares up 16%.
GameStop Shares Dip as Trade-In Promotion Ends, Valuation Questions Loom
GameStop shares slipped 1.6% to $25.24 after a promotional trade-in deal ended, reigniting debate over the company's valuation and its transition to collectibles.
IBM Sales Beat but AI Anxiety Drags Software Stocks Lower
IBM shares tumbled 9.5% despite beating Q1 earnings estimates, as fears that AI tools could erode its software and consulting businesses rattled investors. ServiceNow fell 17.5% and the iShares Expanded Tech-Software ETF lost 5.6%.
Lululemon Stock Drops 12% on CEO Appointment from Nike
Lululemon shares plunged 12% after appointing Heidi O'Neill, a former Nike executive, as CEO. The move comes as the company faces weak U.S. sales and a proxy fight.
Palantir Shares Dip 5% Despite Major USDA Contract; Software Sector Slumps
Palantir shares dropped 5.4% to $144.41 Thursday, overshadowed by a broad software selloff triggered by IBM and ServiceNow results, despite winning a $300 million USDA contract.
Micron Stock Slips from Record as SK Hynix Profit Surge and Export Curbs Loom
Micron Technology shares slipped 2.2% from a record close as SK Hynix reported record profit and AI memory demand exceeds supply. Congress weighs tighter export controls on Chinese rivals.
IBM Shares Tumble 9.9% Despite Q1 Beat as Flat Forecast, AI Worries Weigh
IBM shares fell 9.9% despite beating Q1 estimates, as a flat 2026 forecast and slowing software growth fueled investor concerns over AI's impact.
